Maria A Parker1, Andrea C Villanti1. 1. Vermont Center on Tobacco Regulatory Science, University of Vermont , Burlington , Vermont , USA.
Abstract
Background: In the United States (US), electronic cigarette (e-cigarette) use prevalence has increased since 2010. Few studies, however, have addressed frequency of use at the population-level. This study examines patterns and correlates of e-cigarette use frequency in a novel national sample. Methods: Data were from 36,277 US adults interviewed between 2012 and 2013 for the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Sociodemographic characteristics, other tobacco/drug use, and psychiatric disorders were compared by e-cigarette use status (i.e. current [past-month], past, never) and e-cigarette use frequency (i.e. infrequent [≤3 days/month], moderate [1-6 days/week], daily). Multinomial logistic regression models compared correlates of e-cigarette use status and e-cigarette use frequency. Results: Current e-cigarette use was low in adults (1.4%) and past e-cigarette use was 3.9%. Among current e-cigarette users, 38.1% were infrequent users, 32.9% were moderate users, and 29.0% were daily users. Compared to infrequent e-cigarette users, daily users were more likely to be male and older, but less likely to be current cigarette smokers and alcohol drinkers (p's < .05). Compared to daily e-cigarette users, moderate users were more likely be female, current cigarette smokers, and fall into the 25-34 age group (p's < .05). Moderate and daily e-cigarette users had higher prevalence of current extra-medical opioid use than infrequent users (p's < .05). Conclusions/Importance: E-cigarette users were most often infrequent users versus moderate or daily users. Compared to infrequent and moderate users, daily e-cigarette users were less likely to be current alcohol drinkers or cigarette smokers. Novel findings highlight a correlation between more frequent e-cigarette and opioid use.
Background: In the United States (US), electronic cigarette (e-cigarette) use prevalence has increased since 2010. Few studies, however, have addressed frequency of use at the population-level. This study examines patterns and correlates of e-cigarette use frequency in a novel national sample. Methods: Data were from 36,277 US adults interviewed between 2012 and 2013 for the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Sociodemographic characteristics, other tobacco/drug use, and psychiatric disorders were compared by e-cigarette use status (i.e. current [past-month], past, never) and e-cigarette use frequency (i.e. infrequent [≤3 days/month], moderate [1-6 days/week], daily). Multinomial logistic regression models compared correlates of e-cigarette use status and e-cigarette use frequency. Results: Current e-cigarette use was low in adults (1.4%) and past e-cigarette use was 3.9%. Among current e-cigarette users, 38.1% were infrequent users, 32.9% were moderate users, and 29.0% were daily users. Compared to infrequent e-cigarette users, daily users were more likely to be male and older, but less likely to be current cigarette smokers and alcohol drinkers (p's < .05). Compared to daily e-cigarette users, moderate users were more likely be female, current cigarette smokers, and fall into the 25-34 age group (p's < .05). Moderate and daily e-cigarette users had higher prevalence of current extra-medical opioid use than infrequent users (p's < .05). Conclusions/Importance: E-cigarette users were most often infrequent users versus moderate or daily users. Compared to infrequent and moderate users, daily e-cigarette users were less likely to be current alcohol drinkers or cigarette smokers. Novel findings highlight a correlation between more frequent e-cigarette and opioid use.
Entities:
Keywords:
Electronic cigarettes; United States; epidemiology; frequency; opioids
Authors: Jennifer L Pearson; Sara C Hitchman; Leonie S Brose; Linda Bauld; Allison M Glasser; Andrea C Villanti; Ann McNeill; David B Abrams; Joanna E Cohen Journal: Tob Control Date: 2017-06-17 Impact factor: 7.552
Authors: Michael D Stein; Celeste M Caviness; Kristin Grimone; Daniel Audet; Allison Borges; Bradley J Anderson Journal: J Subst Abuse Treat Date: 2014-11-20
Authors: Scott J Moeller; David S Fink; Misato Gbedemah; Deborah S Hasin; Sandro Galea; Michael J Zvolensky; Renee D Goodwin Journal: J Clin Psychiatry Date: 2018 May/Jun Impact factor: 4.384
Authors: Israel T Agaku; Brian A King; Corinne G Husten; Rebecca Bunnell; Bridget K Ambrose; S Sean Hu; Enver Holder-Hayes; Hannah R Day Journal: MMWR Morb Mortal Wkly Rep Date: 2014-06-27 Impact factor: 17.586
Authors: Luis Zavala-Arciniega; Inti Barrientos-Gutiérrez; Edna Arillo-Santillán; Katia Gallegos-Carrillo; Rosibel Rodríguez-Bolaños; James F Thrasher Journal: Salud Publica Mex Date: 2021-07-29
Authors: Jamie S Church; Fiona Chace-Donahue; Jason L Blum; Jill R Ratner; Judith T Zelikoff; Jared J Schwartzer Journal: Environ Health Perspect Date: 2020-04-15 Impact factor: 9.031
Authors: Luz María Sánchez-Romero; Christopher J Cadham; Jana L Hirschtick; Delvon T Mattingly; Beomyoung Cho; Nancy L Fleischer; Andrew Brouwer; Ritesh Mistry; Stephanie R Land; Jihyoun Jeon; Rafael Meza; David T Levy Journal: BMC Public Health Date: 2021-06-24 Impact factor: 3.295